Ivan Bergstein
2019
In 2019, Ivan Bergstein earned a total compensation of $5.3M as President and Chief Executive Officer at Stemline Therapeutics, a 44% decrease compared to previous year.
Compensation breakdown
| Bonus | $523,750 |
|---|---|
| Non-Equity Incentive Plan | $750,000 |
| Salary | $646,605 |
| Stock Awards | $3,370,626 |
| Total | $5,290,981 |
Bergstein received $3.4M in stock awards, accounting for 64% of the total pay in 2019.
Bergstein also received $523.8K in bonus, $750K in non-equity incentive plan and $646.6K in salary.
Rankings
In 2019, Ivan Bergstein's compensation ranked 2,042nd out of 13,971 executives tracked by ExecPay. In other words, Bergstein earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,042 out of 13,971 | 85th |
Division Manufacturing | 742 out of 5,701 | 87th |
Major group Chemicals And Allied Products | 223 out of 2,200 | 90th |
Industry group Drugs | 180 out of 1,886 | 91st |
Industry Pharmaceutical Preparations | 131 out of 1,398 | 91st |
Source: SEC filing on April 29, 2020.
Bergstein's colleagues
We found three more compensation records of executives who worked with Ivan Bergstein at Stemline Therapeutics in 2019.